• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL LRS PLATELET,PLASMA, RBC AUTO PAS SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL LRS PLATELET,PLASMA, RBC AUTO PAS SET Back to Search Results
Catalog Number 80410
Device Problem Patient-Device Incompatibility (2682)
Patient Problems High Blood Pressure/ Hypertension (1908); Tachycardia (2095); Chills (2191); Reaction (2414)
Event Date 11/16/2015
Event Type  Injury  
Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this double plateletpheresis collection.Review of the rdf indicated the targeted double platelet and plasma collection on the trimaaccel system were collected successfully without incident.The targeted platelet additive solution(pas) volume was added successfully to the platelet product post-collection.There was no indication of events during the product collection or pas addition that could have caused the product to be compromised.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that a patient developed chills, fever, increased blood pressure, and tachycardia during a platelet transfusion procedure.Blood cultures from the patient and the empty platelet bag grew klebsiella pneumaniae.A second platelet concentrate from the same collection was transfused to a different patient without patient reaction, however the patient had been on antibiotics due to his illness.A blood culture was done of the empty bag of this platelet concentrate and showed no bacteria.Plasma was also collected concurrently with the platelet concentrates.A blood culture showed no bacteria in the plasma.Donation and preparation protocols were checked by the customer and were normal.The donor was not ill after the donation.Per the customer, the platelet concentrate came from a double plateletpheresis from (b)(6) 2015.The time between donation and pathogen inactivation was 6 hours.Due to eu personal data protection laws, the patient identifier is not available from the customer.The disposable set is not available for return, because the customer discarded it.
 
Manufacturer Narrative
This report is being filed to provide additional information.Investigation: per literature review, klebsiella pneumoniae is a type of gram-negative bacteria that can cause different types of health-care associated infections.In health care settings, the bacteria can be spread from patient to patient via contaminated hands of health care personnel or exposure through catheters.Klebsiella bacteria are normally found in the human intestines (where they do not cause disease).They are also found in human stool (feces).Per terumo bct's internal quality labs report, the phenomenon of bacterial contamination in blood products is known to occur.Given the nature of microorganisms on human skin and the mechanical act of piercing the skin, it is not possible to completely eliminate bacterial contamination from occurring the devices terumo bct manufactures to collect, separate, and store blood products are terminally sterilized to a sterility assurance level (sal) of
 
Event Description
Follow up discussion with the physician shows that the patient received 40mg solumedrol and 2mg tavegyl in response to the reaction.The next day they started with antibiotic therapy with rocephin after confirmation of the positive blood culture.This therapy continued throughout his stay at the hospital.
 
Manufacturer Narrative
Investigation: a review of the device history record for this unit showed no irregularities during manufacturing that were relevant to this issue.Follow up information from the physician is that the most likely cause is a mild infection from the donor.Between collection and pathogen inactivation, the germ count then grew to a number that was in the "grey zone" of cerus' pi capacity.This explains why the pi could have been successful in one platelet product but not successful in the other bag.Root cause: according to physician statements, the cause for the bacterial infection and transfusion reaction is from a mild infection from the donor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA ACCEL LRS PLATELET,PLASMA, RBC AUTO PAS SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
matthew bickford
10810 w collins ave
lakewood, CO 80215
3032052494
MDR Report Key5353697
MDR Text Key35358369
Report Number1722028-2016-00006
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
BK150269
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 01/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/01/2017
Device Catalogue Number80410
Device Lot Number06Y1117
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/17/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00089 YR
Patient Weight100
-
-